|Grant Affiliation:||Walker: bNabs after Infection and Immunization|
|Strategy:||Prophylactic neutralizing Ab|
|Study Type:||Antibody Screening|
|Study Start Date:||2014-11-21|
|Study Made Public:||2016-02-16|
Monoclonal antibodies from elite controllers who exhibit strong neutralizing antibody breadth
CAVD 469 is an immunogenicity study to develop broadly neutralizing antibodies in HIV infection and following immunization.
Sign in to see full information about this study and to download study data.
ProductsNo Products used in study
No integrated data is available for this study.
NAb non-standard data